Terapia genética

Terapia gênica: esperança para pacientes com beta-talassemia?

Por Joseph Gut - thasso Publicado em September 20, 2022 Publicado em <ph id="mtc_1" equiv-text="base64:JXM="/> Sem comentários Tagged with Anemia, Medicina Teragenomic, Talassemias beta, Terapia genética, Thasso Post, Zynteglo (betibeglogene autotemcel)

16 de setembro de 2022 – As talassemias beta (β talassemias) são um grupo de doenças sanguíneas hereditárias. São formas de talassemia causadas pela síntese reduzida ou ausente das cadeias beta da hemoglobina que resultam em desfechos variáveis que vão …

Terapia gênica: esperança para pacientes com beta-talassemia? Ler mais »

We need your help. Please support the development of thasso through donations. Thank you. Nous avons besoin de votre aide. S'il vous plaît, vous pouvez soutenir le développement de thasso grâce à des dons. Merci. Wir brauchen Ihre Hilfe. Bitte unterstützen Sie die Entwicklung von thasso durch Spenden. Vielen Dank. Abbiamo bisogno del tuo aiuto. Si prega di sostenere lo sviluppo di thasso attraverso donazioni. Grazie. Nós precisamos da sua ajuda. Por favor, apoie o desenvolvimento de thasso através de doações. Obrigada. Necesitamos tu ayuda. Por favor apoye el desarrollo de thasso con donaciones. Muchas gracias.

Scientists uncover novel DNA repair mechanism for key cancer target November 30, 2022
Scientists at the Francis Crick Institute, in collaboration with Artios, have identified how an enzyme involved in DNA repair (POLQ), becomes vital to the survival of certain cancers, if the cancer cells lose the ability to use a more common method of DNA repair.
New genetic culprit suspected in the onset of pancreatic cancer November 30, 2022
New research out of VCU Massey Cancer Center points to the inactivation of a previously unidentified gene as a likely culprit in the development of pancreatic cancer. Recently published in Cell Reports, the findings could alter the scientific understanding of this deadly disease and inform the establishment of novel treatments.
Genetic testing for epilepsy improves patient outcomes November 30, 2022
Genetic testing in patients with epilepsy can inform treatment and lead to better outcomes in many cases, according to a new study published in JAMA Neurology.
Researchers discover genetic variant associated with earlier onset childhood epilepsy November 30, 2022
Researchers at Children's Hospital of Philadelphia (CHOP) have discovered a specific genetic variant in SCN1A, the most common genetic epilepsy, that leads to an earlier onset of epilepsy, with clinical features distinct from other epilepsies. The researchers also identified a potentially effective treatment strategy. The findings were recently published in the journal Epilepsia.
Researchers identify the role of an Alzheimer's disease risk gene in the brain November 30, 2022
A new study links a gene concentrated in the brain's cleanup cells, known as microglia, to the inflammation that has increasingly emerged as a key mechanism contributing to Alzheimer's disease. The findings may offer a new potential target for therapies for the intractable condition.

search thasso

Tag: Terapia genética

Terapia gênica: esperança para pacientes com beta-talassemia?

thasso

keys

meta